hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy
Acute myeloid leukemia cells are often resistant to radiotherapy and chemotherapy. Here, the authors suggest that hCINAP contributes to the resistance of acute myeloid leukemia cells by regulating SUMOylation of Nucleophosmin during the DNA-damage response.
Guardado en:
Autores principales: | Ruidan Xu, Shuyu Yu, Dan Zhu, Xinping Huang, Yuqi Xu, Yimin Lao, Yonglu Tian, Jinfang Zhang, Zefang Tang, Zemin Zhang, Jing Yi, Hong-Hu Zhu, Xiaofeng Zheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/caea99c77e2349bc964a9ae562bf4dbe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adenylate kinase hCINAP determines self-renewal of colorectal cancer stem cells by facilitating LDHA phosphorylation
por: Yapeng Ji, et al.
Publicado: (2017) -
Correction: Corrigendum: Adenylate kinase hCINAP determines self-renewal of colorectal cancer stem cells by facilitating LDHA phosphorylation
por: Yapeng Ji, et al.
Publicado: (2017) -
The ATPase hCINAP regulates 18S rRNA processing and is essential for embryogenesis and tumour growth
por: Dongmei Bai, et al.
Publicado: (2016) -
Priapism due to chronic myelocytic leukemia
por: Syarif, et al.
Publicado: (2022) -
Sensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia
por: Mercedeh Movassagh, et al.
Publicado: (2019)